Baranašić, J.; Šutić, M.; Catalano, C.; Drpa, G.; Huhn, S.; Majhen, D.; Nestić, D.; Kurtović, M.; Rumora, L.; Bosnar, M.;
et al. TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines 2022, 10, 2240.
https://doi.org/10.3390/biomedicines10092240
AMA Style
Baranašić J, Šutić M, Catalano C, Drpa G, Huhn S, Majhen D, Nestić D, Kurtović M, Rumora L, Bosnar M,
et al. TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines. 2022; 10(9):2240.
https://doi.org/10.3390/biomedicines10092240
Chicago/Turabian Style
Baranašić, Jurica, Maja Šutić, Calogerina Catalano, Gordana Drpa, Stefanie Huhn, Dragomira Majhen, Davor Nestić, Matea Kurtović, Lada Rumora, Martina Bosnar,
and et al. 2022. "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line" Biomedicines 10, no. 9: 2240.
https://doi.org/10.3390/biomedicines10092240
APA Style
Baranašić, J., Šutić, M., Catalano, C., Drpa, G., Huhn, S., Majhen, D., Nestić, D., Kurtović, M., Rumora, L., Bosnar, M., Vukić Dugac, A., Sokolović, I., Popovic-Grle, S., Oršolić, N., Škrinjarić-Cincar, S., Jakopović, M., Samaržija, M., Weber, A. N. R., Försti, A.,
& Knežević, J.
(2022). TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines, 10(9), 2240.
https://doi.org/10.3390/biomedicines10092240
